<DOC>
	<DOCNO>NCT02339090</DOCNO>
	<brief_summary>The trial compare twice-monthly somavaratan dose regimen non-inferiority treatment effect daily injection rhGH .</brief_summary>
	<brief_title>Versartis Long-Acting Growth Hormone Children Compared Daily rhGH</brief_title>
	<detailed_description>This study design pivotal study compare safety efficacy select dose regimen somavaratan daily rhGH . The study randomize , multi-center , open label study 12 month duration . The primary endpoint height velocity 12 month .</detailed_description>
	<mesh_term>Growth Disorders</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Chronological Age ≥ 3.0 year ≤ 10.0 ( girl ) ≤ 11.0 ( boy ) . Prepubertal status : Absent breast development girl , testicular volume &lt; 4.0 mL boy . Diagnosis GHD document two GH stimulation test result ≤ 10.0 ng/mL . Height SD score ≤ 2.0 screening . Weight Stature ≥ 10th percentile . IGFI SD score ≤ 1.0 screening . Delayed bone age ( ≥ 6 month ) . Prior treatment growth promote agent History concurrent significant disease ( e.g . diabetes , cystic fibrosis , renal insufficiency ) . Chromosomal aneuploidy , significant gene mutation ( cause GHD ) confirm diagnosis name syndrome . A diagnosis Attention Deficit Hyperactivity Disorder . Daily use antiinflammatory dos glucocorticoid . Prior history leukemia , lymphoma , sarcoma cancer . Treatment investigational drug 30 day prior screen . Known allergy constituent study drug formulation . Ocular finding suggestive increase intracranial pressure and/or retinopathy screening . Significant spinal abnormality include scoliosis , kyphosis spina bifida variant . Significant abnormality screen laboratory study</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>VRS-317</keyword>
	<keyword>Growth Hormone Deficiency</keyword>
	<keyword>Long Acting Recombinant Growth Hormone</keyword>
	<keyword>Long Acting Growth Hormone</keyword>
	<keyword>Pediatric Growth Hormone Deficiency</keyword>
	<keyword>Growth Hormone Replacement Therapy</keyword>
	<keyword>Versartis</keyword>
	<keyword>Xten</keyword>
	<keyword>Human Growth Hormone</keyword>
	<keyword>somavaratan</keyword>
	<keyword>growth failure</keyword>
</DOC>